Company intelligence / Profile preview

Lyfegen

Basel, Basel-Stadt, Switzerland

Ownership: Private
Development stage: Other

Overview

Lyfegen’s Platform is commercially available and automates the negotiation, execution, and compliance of value-based payment models for thousands of agreements. It improves access to therapies by facilitating innovative contracting, pricing, and rebate management globally

Modalities: DrugsDevicesTherapies
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

8 out of the top 10 largest pharma companiesMajor global governments, health insurances, hospitals, and payersUPMC Health PlanEGKSympanyNL Health Services

Beyond the preview

Go deeper on Lyfegen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lyfegen.

Explore the full profile